Package 70069-141-10

{"route": ["INTRAVENOUS"], "spl_id": "757aedc0-ad65-446a-81ed-09afbe8cc595", "openfda": {"upc": ["0370069141014", "0370069151013"], "unii": ["80YS8O1MBS"], "rxcui": ["199212", "1730194"], "spl_set_id": ["ed91f65b-e002-43bd-bfa0-5ce8b89119e6"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (70069-141-01)  / 5 mL in 1 VIAL", "package_ndc": "70069-141-01", "marketing_start_date": "20190204"}, {"sample": false, "description": "10 VIAL in 1 CARTON (70069-141-10)  / 5 mL in 1 VIAL", "package_ndc": "70069-141-10", "marketing_start_date": "20190204"}], "brand_name": "Cisatracurium Besylate", "product_id": "70069-141_757aedc0-ad65-446a-81ed-09afbe8cc595", "dosage_form": "INJECTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "70069-141", "generic_name": "Cisatracurium Besylate", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium Besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA206791", "marketing_category": "ANDA", "marketing_start_date": "20190204", "listing_expiration_date": "20261231"}